145 related articles for article (PubMed ID: 33515898)
21. LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p/CELF1 axis.
Liu C; Wang H; Tang L; Huang H; Xu M; Lin Y; Zhou L; Ho L; Lu J; Ai X
Life Sci; 2021 Jun; 275():119288. PubMed ID: 33667514
[TBL] [Abstract][Full Text] [Related]
22. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3).
Zhang LY; Liu M; Li X; Tang H
J Biol Chem; 2013 Feb; 288(6):4035-47. PubMed ID: 23212913
[TBL] [Abstract][Full Text] [Related]
23. miR-221-3p promotes hepatocellular carcinogenesis by downregulating O6-methylguanine-DNA methyltransferase.
Chen Z; Xiang B; Qi L; Zhu S; Li L
Cancer Biol Ther; 2020 Oct; 21(10):915-926. PubMed ID: 33023393
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression.
Gao J; Yin X; Yu X; Dai C; Zhou F
J Cell Biochem; 2019 Oct; 120(10):16393-16407. PubMed ID: 31270840
[TBL] [Abstract][Full Text] [Related]
25. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
26. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
27. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis.
Zou Y; Sun Z; Sun S
J Biochem; 2020 Nov; 168(5):535-546. PubMed ID: 32663252
[TBL] [Abstract][Full Text] [Related]
28. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA circGFRA1 promotes angiogenesis, cell proliferation and migration of hepatocellular carcinoma by combining with miR-149.
Yu YX; Ge TW; Zhang P
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11058-11064. PubMed ID: 33215421
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.
Guan L; Ji D; Liang N; Li S; Sun B
J Cell Mol Med; 2018 Jul; 22(7):3434-3441. PubMed ID: 29691981
[TBL] [Abstract][Full Text] [Related]
31. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
Zhao L; Wang Y; Liu Q
Exp Mol Pathol; 2019 Aug; 109():51-60. PubMed ID: 31145886
[TBL] [Abstract][Full Text] [Related]
32. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma.
Xia YH; Ren L; Li JZ; Gao F
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539
[TBL] [Abstract][Full Text] [Related]
33. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
34. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J
Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma.
Du C; Weng X; Hu W; Lv Z; Xiao H; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
J Exp Clin Cancer Res; 2015 Jun; 34(1):67. PubMed ID: 26126858
[TBL] [Abstract][Full Text] [Related]
38. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
39. MiR-188-3p and miR-133b Suppress Cell Proliferation in Human Hepatocellular Carcinoma via Post-Transcriptional Suppression of NDRG1.
Luo Z; Fan Y; Liu X; Liu S; Kong X; Ding Z; Li Y; Wei L
Technol Cancer Res Treat; 2021; 20():15330338211033074. PubMed ID: 34355586
[TBL] [Abstract][Full Text] [Related]
40. Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma.
Xu Y; Luo X; He W; Chen G; Li Y; Li W; Wang X; Lai Y; Ye Y
Cell Physiol Biochem; 2018; 49(4):1403-1419. PubMed ID: 30205391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]